Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,100 public trials 1,856 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Completed

Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors

NCT00743379

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +28 more
Locations
  • Mayo Clinic Cancer Center Scottsdale, Arizona, United States
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
  • Indiana University Cancer Center Indianapolis, Indiana, United States
  • LSU Health Sciences Center Shreveport, Louisiana, United States
View Trial Details
Completed

Randomized Trial of ARCON in Larynx Cancer

NCT00147732

Conditions
Head and Neck Neoplasms, Laryngeal Diseases, Laryngeal Neoplasms, +7 more
Locations
  • Free University Medical Centre Amsterdam, Netherlands
  • University Medical Centre Groningen Groningen, Netherlands
  • Leids University Medical Centre Leiden, Netherlands
  • Maastro Clinic Maastricht, Netherlands
View Trial Details
Completed

Lung Screening Study

NCT00006382

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Vincent T. Lombardi Cancer Research Center, Georgetown University Washington D.C., District of Columbia, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • University of Minnesota Cancer Center Minneapolis, Minnesota, United States
View Trial Details
Completed

A Study to Evaluate the Safety and Efficacy of Zoledronic Acid in the Prevention or Delaying of Bone Metastasis in Patients With Stage IIIA and IIIB Non-small Cell Lung Cancer (NSCLC)

NCT00172042

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Novartis Investigative Site Jette, Belgium
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Liège, Belgium
  • Novartis Investigative Site Beijing, China
View all 69 locations
View Trial Details
Completed

Cetuximab in Patients With Lung Adenocarcinoma Receiving Erlotinib That Have Developed "Acquired Resistance" to Erlotinib

NCT00716456

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +10 more
Locations
  • Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States
View Trial Details

Related conditions